Health Law & Policy

Federal Court Requires WA Medicaid to provide HCV Cure to Patients

Today federal district court Judge John C. Coughenour handed patients diagnosed with Hepatitis C virus an unmitigated victory, ordering coverage by the Washington Health Care Authority, the state Medicaid agency, of a cure for Hepatitis C, treatment needed by thousands of Washington Medicaid enrollees. The patients had sued the Washington State Health Care Authority to […]

CHLPI Welcomes Health Law and Policy Clinic 2016 Summer Interns

The Center for Health Law and Policy Innovation is pleased to welcome the following interns working in the Health Law and Policy Clinic for the summer. Bobby Joe Dale III is a rising 3L at the University of Houston Law Center in Houston, TX. In December 2011, he graduated with a B.A. in French from […]

CHLPI Faculty Director Quoted in Philly.com Article on HCV

On Sunday, May 22, 2016, Philly.com printed the article How sick must hepatitis C patients be to get help? The article, written by Don Sapatkin, looks at Medicaid’s refusal to provide access to the cure for Hepatitis C for Pennsylvania residents suffering from the disease. The article includes a quote from CHLPI’s faculty director Robert Greenwald, […]

5/26 | The State of the Alabama Marketplace for People Living with HIV and HCV

The State of the Alabama Marketplace for People Living with HIV and HCV on Thursday, May 26, 2017, from 4:00 – 5:00pm (CDT) at AIDS Alabama, 3529 7th Avenue South, Birmingham, AL 35222. This presentation will present findings from the assessment of the 2016 marketplace plans the Center for Health Law and Policy Innovation conducted, […]

5/27 | Beating HCV: An Open Forum on Opportunities & Challenges for Treating HCV in AL

The Center for Health Law & Policy Innovation (CHLPI) of Harvard Law School and AIDS Alabama will host Beating HCV: An Open Forum on Opportunities and Challenges for Treating Hepatitis C in Alabama on May 27, 2016, from 12:30 – 3:00 pm (CDT) in the Board Room at United Way of Central Alabama, 3600 8th Avenue South, Birmingham, AL 35222 HCV is currently taking […]

CHLPI Featured in Harvard Law Bulletin

The Center for Health Law and Policy Innovation is the main story in the Spring 2016 issue of the Harvard Law Bulletin. The story “The Price of Life” looks a CHLPI’s current work to challenge discrimination by health insurance providers against people living with Hepatitis C, bolstered by a new litigation initiative. The Price of […]

CHLPI Report on Community Joint Use Quoted in The Atlantic

An April 29, 2016 article from The Atlantic looks at the success of Joint Use programs in both San Francisco and New York and the programs’ positive effects on children and the community. Community use, also known as shared use or joint use, refers to the idea of opening public buildings and grounds at times they […]

5/5 | Beating HCV: An Open Forum on Opportunities & Challenges for Treating HCV in MA

The Center for Health Law & Policy Innovation (CHLPI) of Harvard Law School and the Massachusetts Viral Hepatitis Coalition will host Beating HCV: An Open Forum on Opportunities and Challenges for Treating Hepatitis C in Massachusetts on May 5, 2016, from 1:00 – 4:00 pm at the Boston Common Hotel & Conference Center, 40 Trinity Place, Boston, MA 02116. HCV is currently taking […]

CHLPI’s QHP Assessment Noted in Boston Globe Story on Hepatitis C

The latest in a series of articles and op-eds from the Boston Globe, “Hepatitis C patients often have to get sicker before insurance will pay for drugs,”  delves further into the Massachusetts health insurance marketplace and the various insurance providers who have placed restrictions on access to the Hepatitis C cure, despite recommendations from national health […]

CHLPI Litigation Director Quoted in Article from FiercePharma

“New York AG sues insurer over restrictive hep C coverage” originally printed by Emily Wasserman on April 15, 2016 The New York State Attorney General has already taken some steps to find out why insurers are limiting coverage of pricey hep C meds to the sickest patients but has stopped short of suing companies for […]